Pillstats
Rx only · Tablet, Film Coated, Extended Release · Oral

Fesoterodine Fumarate

Brands: Toviaz · Fesoterodine Fumarate

6 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US12 NDCs
6 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
RxCUI (US)797195
US makers6 labelers
Packages22
DEA / ScheduleNone

US acquisition costNADAC · per unit

Average across 10 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.

$0.745$1.49$2.23$2.98Dec 2025Apr 2026Jul 2026
$2.498
Latest avg · Jul 22, 2026
-4%
Since Dec 17, 2025
6
Active US suppliers
55%
Top-2 supplier share*

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

2.8K5.6K8.4K11K2025 Q12025 Q22025 Q32025 Q42026 Q1
6.1K
Rx · 2026 Q1
245K
Units dispensed
-37%
Rx vs. year ago
5
Quarters · since 2025 Q1

Who makes it6 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
Zydus Lifesciences Limitedunknown6SUPPLYING
Zydus Pharmaceuticals USA Inc.unknown6SUPPLYING
Camber Pharmaceuticals, Inc.unknown4SUPPLYING
NorthStar RxLLCunknown2SUPPLYING
Pfizer Laboratories Div Pfizer Incunknown2SUPPLYING
Aurobindo Pharma Limitedunknown2SUPPLYING

Regulatory & supply events

No recalls, shortages, or registration changes on record for this drug concept.